Franz Obermayr
Vorstandsvorsitzender bei Panoptes Pharma GmbH
Aktive Positionen von Franz Obermayr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Vorstandsvorsitzender | 01.07.2013 | - |
| Gründer | 01.07.2013 | - |
Karriereverlauf von Franz Obermayr
Ehemalige bekannte Positionen von Franz Obermayr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.02.2021 | 26.07.2021 |
| Technik-/Wissenschafts-/F&E-Leiter | 18.12.2020 | 31.12.2021 | |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01.01.2009 | 01.01.2013 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 3 |
| Österreich | 2 |
| Irland | 2 |
Operativ
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
- Börse
- Insiders
- Franz Obermayr
- Erfahrung
